Filtros de búsqueda

Lista de obras de

A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE.

artículo científico publicado en 2013

A survey of health care practitioners' knowledge of the QT interval

artículo científico publicado en 2005

Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012

artículo científico publicado en 2014

Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapies

artículo científico publicado en 2010

Adherence and persistence in the use of warfarin after hospital discharge among patients with heart failure and atrial fibrillation

artículo científico publicado en 2013

Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure

artículo científico publicado en 2013

American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association

artículo científico publicado en 2011

Amiodarone use after acute myocardial infarction complicated by heart failure and/or left ventricular dysfunction may be associated with excess mortality

artículo científico publicado en 2007

Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico publicado en 2014

Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease

artículo científico publicado en 2014

Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial

artículo científico publicado en 2016

Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial

artículo científico

Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale

artículo científico publicado en 2010

Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance

artículo científico publicado en 2013

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention

artículo científico publicado en 2015

Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care.

artículo científico publicado en 2016

Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%.

artículo científico publicado en 2014

Atrial fibrillation management strategies and early mortality after myocardial infarction: results from the Valsartan in Acute Myocardial Infarction (VALIANT) Trial

artículo científico publicado en 2010

Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management

artículo científico publicado en 2002

Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial

artículo científico publicado en 2014

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction

artículo científico publicado en 2017

Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)

scientific article published on 07 August 2019

Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.

artículo científico publicado en 2015

Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II.

artículo científico publicado en 2005

Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure

artículo científico

Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial

artículo científico publicado en 2015

Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women

artículo científico publicado en 2016

Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.

artículo científico publicado en 2014

Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease

artículo científico publicado en 2014

Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs

artículo científico publicado en 2015

Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2006

Digoxin and Mortality in Patients With Atrial Fibrillation.

artículo científico publicado en 2018

Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?

artículo científico publicado en 2014

Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial

artículo científico

Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight

artículo científico publicado en 2019

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

article

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

artículo científico publicado en 2012

Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.

artículo científico publicado en 2013

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials

scientific article published on 01 February 2019

High-degree atrioventricular block, asystole, and electro-mechanical dissociation complicating non-ST-segment elevation myocardial infarction

artículo científico publicado en 2015

History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.

artículo científico publicado en 2016

Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry

artículo científico publicado en 2009

How well does early-career investigators' cardiovascular outcomes research training align with funded outcomes research?

artículo científico publicado en 2017

Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥ 65 Years of Age with a Low Ejection Fraction Following Coronary Revascularization

artículo científico publicado en 2020

Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Acute Myocardial Infarction

artículo científico publicado en 2015

Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).

artículo científico publicado en 2008

Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.

artículo científico publicado en 2005

Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials

artículo científico publicado en 2014

Implications of ventricular arrhythmia "bursts" with normal epicardial flow, myocardial blush, and ST-segment recovery in anterior ST-elevation myocardial infarction reperfusion: a biosignature of direct myocellular injury "downstream of downstream"

artículo científico publicado en 2014

Incidence and predictors of sudden cardiac death in patients with diastolic heart failure

artículo científico publicado en 2007

Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy

artículo científico publicado en 2005

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy

artículo científico publicado en 2017

Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?

artículo científico publicado en 2004

Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

artículo científico publicado en 2010

Knowledge deficits related to the QT interval could affect patient safety

scientific article published on 01 April 2003

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

artículo científico

Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures

artículo científico publicado en 2014

Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation

scientific article published on 26 November 2020

Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)

artículo científico publicado en 2010

New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials

artículo científico publicado en 2017

Non-evidence-based ICD implantations in the United States

artículo científico publicado en 2011

Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial

scientific article published on 22 November 2018

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

artículo científico publicado en 2013

Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials

artículo científico publicado en 2014

Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000

artículo científico publicado en 2003

Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

scientific article published on 21 November 2019

Patterns of management of atrial fibrillation complicating coronary artery bypass grafting: Results from the PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT-IV) Trial

artículo científico publicado en 2009

Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank

artículo científico publicado en 2010

Predictable and SuStainable Implementation of National Cardiovascular Registries (PASSION) infrastructure: A think tank report from Medical Device Epidemiological Network Initiative (MDEpiNet)

artículo científico publicado en 2015

Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II.

artículo científico publicado en 2017

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial

artículo científico publicado en 2009

Premature permanent discontinuation of apixaban or warfarin in patients with atrial fibrillation

artículo científico publicado en 2020

Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients

artículo científico publicado en 2003

Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention

artículo científico publicado en 2008

Preventing tomorrow's sudden cardiac death today: part I: Current data on risk stratification for sudden cardiac death

artículo científico publicado en 2007

Preventing tomorrow's sudden cardiac death today: part II: Translating sudden cardiac death risk assessment strategies into practice and policy

artículo científico publicado en 2007

Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis

artículo científico publicado en 2017

Primary prevention implantable cardioverter-defibrillators and survival in older women

artículo científico publicado en 2014

Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients

artículo científico publicado en 2014

Promise of factor Xa inhibition in atrial fibrillation

artículo científico

QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy

artículo científico publicado en 2013

Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practice

artículo científico

Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients With Low Ejection Fraction After Myocardial Infarction.

artículo científico publicado en 2016

Response by Hess et al to Letter Regarding Article, “Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Fai

Response to Letter Regarding Article, "Comparative Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention in Women".

artículo científico publicado en 2016

Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".

artículo científico publicado en 2014

Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”

artículo científico publicado en 2013

Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.

artículo científico publicado en 2010

Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program

artículo científico publicado en 2016

Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure

artículo científico publicado en 2007

Stroke prevention in atrial fibrillation: Closing the gap

artículo científico publicado en 2018

Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome

artículo científico publicado en 2016

Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials

artículo científico publicado en 2013

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials

artículo científico publicado en 2015

Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials

artículo científico publicado en 2013

Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes

artículo científico publicado en 2002

Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial

artículo científico publicado en 2003

Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes

artículo científico

Systematic review of the incidence of sudden cardiac death in the United States

artículo científico publicado en 2011

The Metabolic Syndrome and Risk of Sudden Cardiac Death: The Atherosclerosis Risk in Communities Study

artículo científico publicado en 2017

The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.

artículo científico publicado en 2013

Training cardiovascular outcomes researchers: A survey of mentees and mentors to identify critical training gaps and needs

artículo científico publicado en 2017

Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?

artículo científico publicado en 2012

Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation

artículo científico publicado en 2018

Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation

artículo científico publicado en 2018

Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease

artículo científico publicado en 2009

Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes

artículo científico publicado en 2017

Warfarin use and long-term outcomes in patients with acute myocardial infarction and atrial fibrillation

artículo científico publicado en 2014

Warfarin use and outcomes in patients with atrial fibrillation complicating acute coronary syndromes

artículo científico publicado en 2010